Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein.
about
BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1Identification of WTAP, a novel Wilms' tumour 1-associating proteinPar4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1.The Wilms' tumor gene Wt1 is required for normal development of the retinaThe Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferationThe predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes.Mice lacking the 68-amino-acid, mammal-specific N-terminal extension of WT1 develop normally and are fertile.Insights into the physiological role of WT1 from studies of genetically modified mice.Wilms' tumour: connecting tumorigenesis and organ development in the kidney.New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.WT1 in disease: shifting the epithelial-mesenchymal balance.How mRNA is misspliced in acute myelogenous leukemia (AML)?The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Kruppel-like zinc-finger protein family and WT1 protein isoforms.Actin: a novel interaction partner of WT1 influencing its cell dynamic properties.hnRNP-U directly interacts with WT1 and modulates WT1 transcriptional activation.Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.The Wilms' tumour suppressor protein, WT1, undergoes CRM1-independent nucleocytoplasmic shuttling.S1 proteins C2 and D2 are novel hnRNPs similar to the transcriptional repressor, CArG box motif-binding factor A.Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.Different isoforms of the Wilms' tumour protein WT1 have distinct patterns of distribution and trafficking within the nucleus.Measuring Equilibrium Binding Constants for the WT1-DNA Interaction Using a Filter Binding Assay.A role for SOX9 in post-transcriptional processes: insights from the amphibian oocyte.
P2860
Q24303633-633DC5F6-C428-4E17-B28E-8BF136FA78A1Q28139416-38DEECF8-BFA3-4091-99B1-058AD826D324Q28346512-B34DE0C0-9EB0-4AAB-AC9D-411B7A97AE16Q28507412-8B9E14C5-9A08-47FB-BFED-E898A9B922B2Q28590668-20B1796F-0000-4422-99DA-1C0298741860Q30440624-DB864ABC-B5D9-4348-9223-87A8B12E3B54Q33266516-6472A1E3-131C-418B-A077-AA017C96D38DQ33847590-FF3BB392-1695-4529-BB5F-E98D7230DAD1Q34001125-D7A82AE7-D819-4127-AA59-0F6418403829Q34784768-0D73724D-736C-42F0-8266-16C09DBAD228Q35668754-5D7F5F12-B23A-431F-AC20-E2B772619AB9Q36234726-2A200523-3BD5-4B3B-A27F-2FD00682642EQ37127104-C2CDDB69-926D-4521-9D58-78D43584A7C6Q37940867-87B0045A-F2C9-4DCE-8D80-A7FA6178A936Q38265600-B24422C6-823B-48F4-8735-2C535C98935EQ38287924-18B70C5F-970D-42AC-9942-873506650456Q39686531-7D04D314-60A0-4E25-A86A-605003F25DFCQ39766194-D0881A17-FD34-498D-917A-CC0B44131055Q40241092-D5F1700E-E5AB-4DC7-95DD-859F34C1DFD7Q40452198-22775328-BA11-49B4-94DB-DE00B10F079EQ40578390-398155C1-A82F-467E-B0BF-2AB077B8B6BFQ40620494-1082A45B-5C9C-49BE-805F-554225B07EC4Q40795616-0BA32E4E-4922-406F-B956-CC44D40E8C56Q47281345-B844D9AA-1F18-4BEE-A0F1-F1F0AAB12537Q47294532-D2BD7137-AB5D-4F40-AA76-63C17CF0B4DFQ50707897-1E084EDB-4BB6-4CBD-AE9F-F46856E1E788Q51640813-19B1761E-174A-4E01-A066-BBC06E2B4AE4Q55024500-3303203A-2C00-467D-8DDE-1BBE97E8DD72
P2860
Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Presence of WT1, the Wilm's tu ...... poly(A)(+) ribonucleoprotein.
@ast
Presence of WT1, the Wilm's tu ...... poly(A)(+) ribonucleoprotein.
@en
type
label
Presence of WT1, the Wilm's tu ...... poly(A)(+) ribonucleoprotein.
@ast
Presence of WT1, the Wilm's tu ...... poly(A)(+) ribonucleoprotein.
@en
prefLabel
Presence of WT1, the Wilm's tu ...... poly(A)(+) ribonucleoprotein.
@ast
Presence of WT1, the Wilm's tu ...... poly(A)(+) ribonucleoprotein.
@en
P2093
P2860
P356
P1476
Presence of WT1, the Wilm's tu ...... poly(A)(+) ribonucleoprotein.
@en
P2093
P2860
P304
36520-36526
P356
10.1074/JBC.274.51.36520
P407
P577
1999-12-01T00:00:00Z